STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5. Issue 9 (26th August 2010)

• Record Type: Journal Article
• Authors: Cetica, Valentina; Santoro, Alessandra; Gilmour, Kimberly C; Sieni, Elena; Beutel, Karin; Pende, Daniela; Marcenaro, Stefania; Koch, Florian; Grieve, Samantha; Wheeler, Rachel; Zhao, Fang; zur Stadt, Udo; Griffiths, Gillian M; Aricò, Maurizio
• Is Part Of: Journal of medical genetics. Volume 47:Issue 9(2010)
• Page Start: 595
• Page End: 600
• Publication Date: 2010-08-26
• Subjects: Degranulation -- syntaxin -- cytotoxicity -- molecular genetics -- haematology (incl Blood transfusion); Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmg.2009.075341
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Background: Familial haemophagocytic lymphohistiocytosis (FHL) is a rare immune deficiency with uncontrolled inflammation; the clinical course usually starts within the first years of life, and is usually fatal unless promptly treated and then cured with haematopoietic stem cell transplant. FHL is caused by genetic mutations resulting in defective cell cytotoxicity; three disease related genes have been identified to date: perforin, Munc13-4 and syntaxin-11. A fourth gene, STXBP2, has been identified very recently as responsible for a defect in Munc18-2 in FHL-5. Aims: To describe the result of the screening of families with HLH and previously unassigned genetic defects. Methods: Patients with HLH diagnosed according to current diagnostic criteria, and who lacked mutations in the PRF1, Munc13-4, and STX11 genes were sequenced for mutations in STXBP2. Functional study was performed when material was available. Results: Among the 28 families investigated, 4 (14%) with biallelic STXBP2 mutations were identified. They originated from Italy, England, Kuwait and Pakistan. The p.Pro477Leu resulting from c.1430C>T, and p.Arg405Gln resulting from the single c.1214G>A nucleotide change are known, while we contribute two novel mutations: p.Glu132Ala resulting from c.395A>C, and p.Gly541Ser, resulting from c.1621G>A. The detrimental effect of the p.Gly541Ser mutation was documented biochemically and functionally in NK and CD8 cells. Additional polymorphisms are also described. Conclusion: These data expand current knowledge on the genetic heterogeneity of FHL and suggest that patients with FHL5 may have different results in degranulation assays under different conditions.